Blood pressure variability predicts cardiovascular events independently of traditional cardiovascular risk factors and target organ damage: A LIFE substudy

Journal of Hypertension

Volumn 33, Issue 12, 2015, Pages 2422-2430

  Vishram, Julie K K ^a,b   Dahlöf, Björn ^c   Devereux, Richard B ^d   Ibsen, Hans ^e   Kjeldsen, Sverre E ^f   Lindholm, Lars H ^g   Mancia, Giuseppe ^h   Okin, Peter M ^d   Rothwell, Peter M ⁱ   Wachtell, Kristian ^j   Olsen, Michael H ^k,l  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b NAESTVED HOSPITAL   (Denmark)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e Holbæk University Hospital   (Denmark)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g UMEÅ UNIVERSITY   (Sweden)

^h ISTITUTO AUXOLOGICO ITALIANO   (Italy)

ⁱ JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k ODENSE UNIVERSITY HOSPITAL   (Denmark)

^l NORTH WEST UNIVERSITY   (South Africa)

more..

Author keywords

blood pressure variability; cardiovascular risk; epidemiology; target organ damage

Indexed keywords

ALBUMIN; ATENOLOL; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOSARTAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CREATININE URINE LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; VERY ELDERLY; ALBUMINURIA; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STROKE; URINE;

AGED; AGED, 80 AND OVER; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CREATININE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOSARTAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84947020304     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000739     Document Type: Article

References (34)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. BP, stroke and coronary heart disease. Part 1, Prolonged differences in BP: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual BP to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
3. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:895-905.
4. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, et al. Effects of beta blockers and calcium-channel blockers on withinindividual variability in blood pressure and risk of stroke. Lancet Neurol 2010; 9:469-480.
5. Diaz KM, Tanner RM, Falzon L, Levitan EB, Reynolds K, Shimbo D, et al. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension 2014; 64:965-982.
6. Chowdhury EK, Owen A, Krum H, Wing LM, Nelson MR, Reid CM, et al. Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients. J Hypertens 2014; 32:525-533.
7. Hata Y, Kimura Y, Muratani H, Fukiyama K, Kawano Y, Ashida T, et al. Office blood pressure variability as a predictor of brain infarction in elderly hypertensive patients. Hypertens Res 2000; 23:553-560.
8. Eguchi K, Hoshide S, Schwartz JE, Shimada K, Kario K. Visit-to-visit ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens 2012; 25:962-968.
9. Hata Y, Muratani H, Kimura Y, Fukiyama K, Kawano Y, Ashida T, et al. Office blood pressure variability as a predictor of acute myocardial infarction in elderly patients receiving antihypertensive therapy. J Hum Hypertens 2002; 16:141-146.
10. Kilpatrick ES, Rigby AS, Atkin SL. The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care 2010; 33:2442-2447.
11. Kawai T, Ohishi M, Kamide K, Onishi M, Takeya Y, Tatara Y, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res 2012; 35:239-243.
12. Okada H, Fukui M, Tanaka M, Inada S, Mineoka Y, Nakanishi N, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012; 220:155-159.
13. Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R. Blood pressure variability and multiple organ damage in primary hypertension. J Hum Hypertens 2013; 27:663-670.
14. Ryu J, Cha RH, Kim DK, Lee JH, Yoon SA, Ruy DR, et al. The clinical association of the blood pressure variability with the target organ damage in hypertensive patients with chronic kidney disease. J Korean Med Sci 2014; 29:957-964.
15. Gómez Angelats E, Sierra C, Coca A, Paré JC, de la Sierra A. Lack of association between blood pressure variability and left ventricular hypertrophy in essential hypertension. Med Clin (Barc) 2004; 123:731-734.
16. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57:160-166.
17. Mancia G, Messerli F, Bakris G, Zhou Q, Champion A, Pepine CJ. Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study. Hypertension 2007; 50:299-305.
18. Dahlöf B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Hypertension 1998; 32:989-997.
19. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995-1003.
20. Rowe DJ, Dawnay A, Watts GF. Microalbuminuria in diabetes mellitus: a review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 1990; 27 (Pt 4):297-312.
21. Borch-Johnsen K, Wenzel H, Viberti GC, Mogensen CE. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ 1993; 306:1722-1725.
22. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83:356-362.
23. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensivedrug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010; 375:906-915.
24. Wardlaw JM, Farall A, Amitage PA, Carpenter T, Chappell F, Doubal F, et al. Changes in background blood-brain barrier between lacunar and cortical ischemic stroke subtypes. Stroke 2008; 39:1327-1332.
25. Shimbo D, Shea S, McClelland RL, Viera AJ, Mann D, Newman J, et al. Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens 2013; 26:896-902.
26. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011; 5:184-192.
27. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375:938-948.
28. Parati G, Bilo G. Calcium antagonist added to angiotensin receptor blocker: a recipe for reducing blood pressure variability? Evidence from day-by-day home blood pressure monitoring. Hypertension 2012; 59:1091-1093.
29. Mattace-Raso FU, van den Meiracker AH, Bos WJ, van der Cammen TJ, Westerhof BE, Elias-Smale S, et al. Arterial stiffness, cardiovagal baroreflex sensitivity and postural blood pressure changes in older adults: the Rotterdam Study. J Hypertens 2007; 25:1421-1426.
30. Parati G, Lantelme P. Mechanical and neural components of the cardiac baroreflex: new insights into complex physiology. J Hypertens 2005; 23:717-720.
31. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 2012; 126:569-578.
32. Woythaler JN, Singer SL, Kwan OL, Meltzer RS, Reubner B, Bommer W, et al. Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: comparison with postmortem mass measurements. J Am Coll Cardiol 1983; 2:305-311.
33. Myerson SG, Montgomery HE, World MJ, Pennell DJ. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension 2002; 40:673-678.
34. Eshøj O, Feldt-Rasmussen BO, Larsen ML, Mogensen EF. Comparison of overnight, morning and 24-our urine collections in the assessment of diabetic microalbuminuria. Diabet Med 1987; 4:531-533.